204 related articles for article (PubMed ID: 34072343)
1. The Role of Non-Specific Interactions in Canonical and ALT-Associated PML-Bodies Formation and Dynamics.
Fonin AV; Silonov SA; Shpironok OG; Antifeeva IA; Petukhov AV; Romanovich AE; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072343
[TBL] [Abstract][Full Text] [Related]
2. New Evidence of the Importance of Weak Interactions in the Formation of PML-Bodies.
Fonin AV; Silonov SA; Fefilova AS; Stepanenko OV; Gavrilova AA; Petukhov AV; Romanovich AE; Modina AL; Zueva TS; Nedelyaev EM; Pleskach NM; Kuranova ML; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163537
[TBL] [Abstract][Full Text] [Related]
3. On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.
Silonov SA; Mokin YI; Nedelyaev EM; Smirnov EY; Kuznetsova IM; Turoverov KK; Uversky VN; Fonin AV
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136675
[TBL] [Abstract][Full Text] [Related]
4. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
[TBL] [Abstract][Full Text] [Related]
5. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
Chung I; Leonhardt H; Rippe K
J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
[TBL] [Abstract][Full Text] [Related]
6. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
[TBL] [Abstract][Full Text] [Related]
7. PML body meets telomere: the beginning of an ALTernate ending?
Chung I; Osterwald S; Deeg KI; Rippe K
Nucleus; 2012; 3(3):263-75. PubMed ID: 22572954
[TBL] [Abstract][Full Text] [Related]
8. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
9. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
10. PML Bodies in Mitosis.
Lång A; Lång E; Bøe SO
Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
[TBL] [Abstract][Full Text] [Related]
12. PML nuclear bodies and chromatin dynamics: catch me if you can!
Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
[TBL] [Abstract][Full Text] [Related]
13. PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity.
Zhang Y; Shao AW; Tang J; Geng Y
Biochem Biophys Res Commun; 2021 May; 554():186-192. PubMed ID: 33798946
[TBL] [Abstract][Full Text] [Related]
14. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
16. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
Li C; Peng Q; Wan X; Sun H; Tang J
J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
18. PML Body Biogenesis: A Delicate Balance of Interactions.
Silonov SA; Smirnov EY; Kuznetsova IM; Turoverov KK; Fonin AV
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069029
[TBL] [Abstract][Full Text] [Related]
19. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
[TBL] [Abstract][Full Text] [Related]
20. Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Loe TK; Li JSZ; Zhang Y; Azeroglu B; Boddy MN; Denchi EL
Genes Dev; 2020 May; 34(9-10):650-662. PubMed ID: 32217664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]